{"id":56419,"date":"2026-02-05T20:46:03","date_gmt":"2026-02-05T12:46:03","guid":{"rendered":"https:\/\/flcube.com\/?p=56419"},"modified":"2026-02-05T20:46:04","modified_gmt":"2026-02-05T12:46:04","slug":"pfizer-launches-migraine-management-zone-at-china-pharmacy","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=56419","title":{"rendered":"Pfizer Launches Migraine Management Zone at China Pharmacy"},"content":{"rendered":"\n<p><strong>Pfizer Inc.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/PFE:NYSE\">NYSE:\u202fPFE<\/a>) in collaboration with <strong>GuoDa Drugstore Co., Ltd.<\/strong> (part of Sinopharm) this week launched a dedicated <strong>Migraine Category Zone<\/strong> at the Nanjing West Road store in Shanghai. The initiative transforms the retail pharmacy from traditional product display into a comprehensive disease management service model covering awareness, risk screening, medication guidance, and follow-up management.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-partnership-structure-amp-strategic-terms\">Partnership Structure &amp; Strategic Terms<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Companies<\/strong><\/td><td>Pfizer Inc. (NYSE:\u202fPFE) \/ GuoDa Drugstore Co., Ltd. (Sinopharm)<\/td><\/tr><tr><td><strong>Location<\/strong><\/td><td>Nanjing West Road store, Shanghai<\/td><\/tr><tr><td><strong>Initiative<\/strong><\/td><td>Migraine Category Zone<\/td><\/tr><tr><td><strong>Service Model<\/strong><\/td><td>Disease awareness, risk screening, standardized medication guidance, follow-up management<\/td><\/tr><tr><td><strong>Strategic Goal<\/strong><\/td><td>Enhance migraine patient access and continuity of standardized diagnosis and treatment<\/td><\/tr><tr><td><strong>Expansion Plan<\/strong><\/td><td>Explore nationwide replication of the model<\/td><\/tr><tr><td><strong>Market Focus<\/strong><\/td><td>Migraine and chronic disease management in retail pharmacy setting<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-impact-amp-strategic-implications\">Market Impact &amp; Strategic Implications<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>China Migraine Market:<\/strong> Affects <strong>~100\u202fmillion<\/strong> : patients; current diagnosis and treatment rates remain below <strong>20%<\/strong>, creating significant unmet need<\/li>\n\n\n\n<li><strong>Retail Pharmacy Transformation:<\/strong> Disease management zones represent <strong>\u00a550\u202fbillion<\/strong> (~US$7\u202fbillion) market opportunity in chronic disease services<\/li>\n\n\n\n<li><strong>Patient Access:<\/strong> Dedicated zones improve medication accessibility and provide systematic service experience, potentially increasing patient adherence by <strong>30\u201340%<\/strong><\/li>\n\n\n\n<li><strong>Professional Capabilities:<\/strong> Partnership elevates pharmacy staff training in migraine management, creating a replicable model for other chronic diseases<\/li>\n\n\n\n<li><strong>Nationwide Replication:<\/strong> Success in Shanghai flagship store could scale to <strong>1,000+<\/strong> Sinopharm locations across China by 2027<\/li>\n\n\n\n<li><strong>Revenue Synergies:<\/strong> While direct sales impact is modest, the model strengthens Pfizer&#8217;s brand loyalty and prescription pull\u2011through for migraine portfolio (including Nurtec)<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding partnership expansion timelines, patient adoption rates, and revenue projections for the migraine management model. Actual results may differ due to competitive responses, regulatory changes, and patient acceptance.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pfizer Inc. (NYSE:\u202fPFE) in collaboration with GuoDa Drugstore Co., Ltd. (part of Sinopharm) this week&#8230;<\/p>\n","protected":false},"author":1,"featured_media":56421,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[863,78,309,2311],"class_list":["post-56419","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-nyse-pfe","tag-otc-retail","tag-pfizer","tag-sinopharm-group-company"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Pfizer Launches Migraine Management Zone at China Pharmacy - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Pfizer Inc. (NYSE:\u202fPFE) in collaboration with GuoDa Drugstore Co., Ltd. (part of Sinopharm) this week launched a dedicated Migraine Category Zone at the Nanjing West Road store in Shanghai. The initiative transforms the retail pharmacy from traditional product display into a comprehensive disease management service model covering awareness, risk screening, medication guidance, and follow-up management.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=56419\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pfizer Launches Migraine Management Zone at China Pharmacy\" \/>\n<meta property=\"og:description\" content=\"Pfizer Inc. (NYSE:\u202fPFE) in collaboration with GuoDa Drugstore Co., Ltd. (part of Sinopharm) this week launched a dedicated Migraine Category Zone at the Nanjing West Road store in Shanghai. The initiative transforms the retail pharmacy from traditional product display into a comprehensive disease management service model covering awareness, risk screening, medication guidance, and follow-up management.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=56419\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-05T12:46:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-05T12:46:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/02\/0505.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=56419#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=56419\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Pfizer Launches Migraine Management Zone at China Pharmacy\",\"datePublished\":\"2026-02-05T12:46:03+00:00\",\"dateModified\":\"2026-02-05T12:46:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=56419\"},\"wordCount\":287,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=56419#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/0505.webp\",\"keywords\":[\"NYSE: PFE\",\"OTC \\\/ retail\",\"Pfizer\",\"Sinopharm Group Company\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=56419#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=56419\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=56419\",\"name\":\"Pfizer Launches Migraine Management Zone at China Pharmacy - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=56419#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=56419#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/0505.webp\",\"datePublished\":\"2026-02-05T12:46:03+00:00\",\"dateModified\":\"2026-02-05T12:46:04+00:00\",\"description\":\"Pfizer Inc. (NYSE:\u202fPFE) in collaboration with GuoDa Drugstore Co., Ltd. (part of Sinopharm) this week launched a dedicated Migraine Category Zone at the Nanjing West Road store in Shanghai. The initiative transforms the retail pharmacy from traditional product display into a comprehensive disease management service model covering awareness, risk screening, medication guidance, and follow-up management.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=56419#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=56419\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=56419#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/0505.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/0505.webp\",\"width\":1080,\"height\":608,\"caption\":\"Pfizer Launches Migraine Management Zone at China Pharmacy\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=56419#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pfizer Launches Migraine Management Zone at China Pharmacy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pfizer Launches Migraine Management Zone at China Pharmacy - Insight, China&#039;s Pharmaceutical Industry","description":"Pfizer Inc. (NYSE:\u202fPFE) in collaboration with GuoDa Drugstore Co., Ltd. (part of Sinopharm) this week launched a dedicated Migraine Category Zone at the Nanjing West Road store in Shanghai. The initiative transforms the retail pharmacy from traditional product display into a comprehensive disease management service model covering awareness, risk screening, medication guidance, and follow-up management.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=56419","og_locale":"en_US","og_type":"article","og_title":"Pfizer Launches Migraine Management Zone at China Pharmacy","og_description":"Pfizer Inc. (NYSE:\u202fPFE) in collaboration with GuoDa Drugstore Co., Ltd. (part of Sinopharm) this week launched a dedicated Migraine Category Zone at the Nanjing West Road store in Shanghai. The initiative transforms the retail pharmacy from traditional product display into a comprehensive disease management service model covering awareness, risk screening, medication guidance, and follow-up management.","og_url":"https:\/\/flcube.com\/?p=56419","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-02-05T12:46:03+00:00","article_modified_time":"2026-02-05T12:46:04+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/02\/0505.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=56419#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=56419"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Pfizer Launches Migraine Management Zone at China Pharmacy","datePublished":"2026-02-05T12:46:03+00:00","dateModified":"2026-02-05T12:46:04+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=56419"},"wordCount":287,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=56419#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/02\/0505.webp","keywords":["NYSE: PFE","OTC \/ retail","Pfizer","Sinopharm Group Company"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=56419#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=56419","url":"https:\/\/flcube.com\/?p=56419","name":"Pfizer Launches Migraine Management Zone at China Pharmacy - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=56419#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=56419#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/02\/0505.webp","datePublished":"2026-02-05T12:46:03+00:00","dateModified":"2026-02-05T12:46:04+00:00","description":"Pfizer Inc. (NYSE:\u202fPFE) in collaboration with GuoDa Drugstore Co., Ltd. (part of Sinopharm) this week launched a dedicated Migraine Category Zone at the Nanjing West Road store in Shanghai. The initiative transforms the retail pharmacy from traditional product display into a comprehensive disease management service model covering awareness, risk screening, medication guidance, and follow-up management.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=56419#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=56419"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=56419#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/02\/0505.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/02\/0505.webp","width":1080,"height":608,"caption":"Pfizer Launches Migraine Management Zone at China Pharmacy"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=56419#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Pfizer Launches Migraine Management Zone at China Pharmacy"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/02\/0505.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/56419","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=56419"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/56419\/revisions"}],"predecessor-version":[{"id":56422,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/56419\/revisions\/56422"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/56421"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=56419"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=56419"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=56419"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}